Amphotericin B Liposome for Injection recall: Subpotent
Amphotericin B Liposome for Injection, 50mg/vial, Rx only, Distributed by Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, Manufactured by Sun Pharmaceutical Medicare Limited, Baska Ujeti Road, Ujeti, Halol-389350, Gujarat, India, NDC 62756-0233-01
Why was Amphotericin B Liposome for Injection recalled?
Subpotent drug
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot # BAD0089A, Exp 01/2025; BAD0330A, Exp 07/2025
- Product
- Amphotericin B Liposome for Injection, 50mg/vial, Rx only, Distributed by Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, Manufactured by Sun Pharmaceutical Medicare Limited, Baska Ujeti Road, Ujeti, Halol-389350, Gujarat, India, NDC 62756-0233-01
- Recalling firm
- SUN PHARMACEUTICAL INDUSTRIES INC
- Quantity
- 12960 vials
- Distribution
- USA nationwide
- Recall date
- July 5, 2023
- Classification
- Class II
- Status
- Terminated
- Agency
- FDA (drug)